Confident low-flow anesthesia

Aisys CS² End-tidal Control software

Designed to complement the expertise of anesthesia providers in managing complex cases in the operating room, End-tidal Control (Et Control) software* for the Aisys™ CS² anesthesia machine allows anesthesia providers to set targets for end-tidal oxygen (EtO2) and anesthetic agent (EtAA). Et Control automatically adjusts fresh gas concentrations to quickly achieve and maintain those targets, regardless of changes in the patient's hemodynamic and metabolic status.
 

Benefits of End-tidal Control

 

Clinically safe

One study has indicated that, when used as indicated, Et Control is as clinically safe as manual fresh gas control1

Fast, low-flow⁶ control

Reach 90% of your target EtAA within an average of 90 seconds³ and maintain the target at minimal flow rates

Reduced workloads

One study has shown it can reduce the number of key presses by >50%4 to help simplify adoption of low-flow strategies by your staff

Vigilant patient support

One study has shown that End-tidal control is twice as accurate at maintaining the set targets than manual control, regardless of patient status1

Eco-friendly practices

One study has shown a potential 44% decline in the rate of greenhouse emissions5 when employing Et Control software

Improved cost savings

Studies have shown it can reduce anesthetic agent consumption by over 25% depending on agent1,4
 

Functionality & FAQs

 

How it works

Read this summary of how Et Control software functions and the safety mechanisms the system takes to prevent delivering a hypoxic mixture.

Download data sheet


Frequently asked questions

Download the FAQs to learn how you can safely practice low-flow6 anesthesia using Et Control software for automating the delivery of EtO₂ and EtAA to maintain clinician set targets.

Get the FAQs


Learn how End-tidal Control operates

Watch this whiteboard video that explains the fundamentals of Et Control software for automatically adjusting fresh gas flow concentrations.

Watch video


Compare Et Control software to ecoFLOW software

Understand how each software differs and helps support low-flow anesthesia practices.

Download flyer

Stay ahead with the latest insights and thinking in Anesthesia

 

Sustained Adoption of End-Tidal Control: A Paradigm Shift in Anesthesia Delivery

Read this summary of a study highlighting the observed economic and environmental benefits from using End-tidal Control (EtC) software.

 

Key Outcomes with End-tidal Control in a Randomized Controlled Study: The MASTER Trial

The following is a summary of the MASTER Trial, highlighting key outcomes with the automation of inhalational anesthetic and oxygen delivery using End-tidal Control.

 

In-depth exploration on Low-flow⁶ Anesthesia | ASA

Discover how low-flow⁶ anesthesia may improve patient care, efficiency, and sustainability—featuring practical insights from leading experts

 

End-tidal Control data highlights

 

Review literature published on the use of Et Control software for automating fresh gas flow concentrations in the operating room.

Download white paper

Download literature summary

Footnotes
  1. Refer to GE HealthCare Et Control Pivotal Study Report DOC2163005. When used as indicated, Et Control is as clinically safe as manual fresh gas control.
  2. The number 2 footnote has been omitted to avoid any confusion with the Aisys CS2 product name.
  3. Et Control user’s reference manual (5824844-USA), Et Control Accuracy Graph.
  4. S. Singaravelu and P. Barclay, Automated control of end-tidal inhalation anaesthetic concentration using the GE Aisys Carestation. British Journal of Anaesthesia 2013; 110 (4): 561–6.
  5. Tay. S, et al. Financial and environmental costs of manual versus automated control of end-tidal gas concentrations, Anaesthesia Intensive Care 2013; 41: 95-105.
  6. Refer to the anesthetic agent labeling for information regarding indications for use, warnings, and other relevant clinical information specific to that anesthetic agent. Any decisions regarding selection of anesthetic agent and flow rate should be made at the discretion of the clinician and in their medical judgment based on available information.

* Et Control in the United States is indicated for patients 18 years of age and older.

Aisys is a trademark of GE HealthCare.

Have a question? We'd love to hear from you.

JB07028XX